AI Science Tracker
EN

Machine Learning Analysis of Immune Cells for Diagnosis and Prognosis of Cutaneous Melanoma.

Affiliation not stated in the reviewed material · 27 Jan 2022 · medicine

Discovery

Machine Learning Analysis of Immune Cells for Diagnosis and Prognosis of Cutaneous Melanoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine learning on five melanoma expression cohorts produced diagnostic/prognostic immune-cell signatures and a disease-specific high-risk immune phenotype.

Technology: ssGSEA quantified 24 immune-cell populations; multiple ML feature-selection/classification methods selected diagnostic and prognostic patterns.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
ssGSEA quantified 24 immune-cell populations; multiple ML feature-selection/classification methods selected diagnostic and prognostic patterns.
Test and result
Results include tumor/control immune-cell differences and survival-risk subgroup associations in melanoma datasets.
Limitation / still unknown
Retrospective GEO/TCGA cohorts and cross-dataset analysis; no prospective clinical validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8813285/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC8813285/#methods · https://pmc.ncbi.nlm.nih.gov/articles/PMC8813285/#results

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.